Why is Torrent Pharma falling/rising?

As of 29-Jul, Torrent Pharmaceuticals Ltd. is experiencing a positive price movement, with its current price at Rs. 3,778.00, reflecting an increase of 148.5 (4.09%). The stock has recently hit a new 52-week high and has outperformed its sector by 2.68%. Over the past three days, it has gained 7.73%, and it is trading above all key moving averages, indicating strong momentum. Despite a slight decline in investor participation, as evidenced by a 22.07% drop in delivery volume, the company maintains high management efficiency with a return on capital employed (ROCE) of 22.33% and a low debt to EBITDA ratio of 1.26 times. Positive results over the last eight consecutive quarters and consistent returns over the past three years further bolster investor confidence, although concerns about long-term growth persist due to a modest annual net sales growth rate of 7.72% over the last five years.
In the broader market context, Torrent Pharmaceuticals has significantly outperformed the Sensex, with a one-week return of +7.84% compared to the benchmark's -1.03%. This trend continues over the one-month period, where the stock rose by +11.94% while the Sensex declined by -3.24%. The strong institutional holdings at 24.75% suggest that knowledgeable investors are backing the stock, which may contribute to its upward trajectory. However, the stock's high valuation metrics, including a PEG ratio of 3, indicate that while it is performing well in the short term, there are underlying risks that could affect its long-term growth potential.